American Society of Hematology

ASH Meeting on Hematologic Malignancies

September 7-8, 2018
Marriott Marquis Chicago, Chicago, IL

 Add to calendar 09/07/2018 07:00 AM09/08/2018 08:00 PMASH Meeting on Hematologic MalignanciesHear the top experts in hematologic malignancies discuss the latest developments in clinical care and find answers to your most challenging patient care questions.Marriott Marquis Chicago, Chicago, ILMM/DD/YYYY129600
   Get email updates

Register now for the 2018 meeting.

The ASH Meeting on Hematologic Malignancies features the top experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues in an intimate, small-group setting with no competing sessions. Attend the 2018 meeting to hear experts present cutting-edge scientific data, provide outside-the-box treatment approaches, answer challenging patient care questions during topic-based panel discussions, and engage in stimulating conversations on specific disease topics during “Lunch With the Experts” sessions.

The program content is structured as "How I Treat" presentations, which showcase each speaker's evidence-based treatment approaches. Learn how new data can be translated into new strategies for diagnosis and treatment, find out what to do in cases where there is no data, and gain knowledge that can help you make an immediate impact on your practice.

Hear exciting updates in each of the core hematologic malignancies, including:

Download the ASH Meetings App

The ASH Meetings app provides access to valuable information and resources for any regional ASH meeting for which you have registered. You can use the app to view the full meeting program and schedule, follow along with presentation slides, create a custom itinerary, browse speaker bios, and more. Plan ahead by downloading the ASH Meetings app now—content for the 2018 ASH Meeting on Hematologic Malignancies will be available in early September.

Download for iOS | Download for Android

Program Co-Chairs

John P. Leonard, MD

John P. Leonard, MD
Weill Cornell Medical
College

S. Vincent Rajkumar, MD

S. Vincent Rajkumar, MD
Mayo Clinic

Gail Roboz, MD

Gail Roboz, MD
Weill Cornell Medical
College

Program Planning Committee

  • Anjali Advani, MD, Cleveland Clinic
  • Jonathan W. Friedberg, MD, University of Rochester
  • Irene Ghobrial, MD, Dana-Farber Cancer Institute
  • Ruben A. Mesa, MD, UT Health San Antonio Cancer Center

Exposition

ASH would like to acknowledge the following companies for exhibiting at the 2018 ASH Meeting on Hematologic Malignancies. Participants in this exposition are comprised of the most renowned companies in the industry, including:

  • Amgen, Inc.
  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals
  • Celgene Corporation
  • Genentech
  • Gilead Sciences, Inc.
  • Incyte Corporation
  • Merck & Co.
  • Novartis
  • Pfizer, Inc.
  • Seattle Genetics

For information about sponsoring and/or exhibiting at this meeting, contact Thelma Barnett at corporatesupport@hematology.org.

Corporate Support

ASH would like to acknowledge the following companies for the educational grants provided in support of the 2018 ASH Meeting on Hematologic Malignances.

  • AbbVie, Inc.
  • Amgen, Inc.
  • AstraZeneca
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Incyte Corporation
  • Jazz Pharmaceuticals
  • Merck & Co.
  • Pfizer, Inc.
  • Pharmacyclics, An AbbVie Company

Related Content

back to top